- Grants since 2016
- 484
- Awarded, last 5 years (where amounts are published)
- 57M
- Funded works, last 5 years
- 437
- Funded works, all time
- 2 006
Grants
2018–2020 · award
Enabling the description of the cognitive and behavioural profile in South African ALS patients
Jeannine Heckmann
2018 · award
Teva crowdsourcing challenge: novel therapeutics targets for disorders of the central nervous system
Innocentive, Inc.
2018–2019 · award
Treatment of ALS by targeted delivery of GDNF to motoneurons using novel V-SmartTM nanovesicles
Eliahu Heldman
2018–2019 · award
Ataxin 2 Neuropathology in Sporadic ALS
John Ravits
2018–2021 · award
Identifying genetic and small molecular modifiers of FUS-mediated ALS
Udai Pandey
2018–2021 · award
Identification of novel therapeutic targets for ALS using a photoinducible DLK (Dual Leucine Zipper Kinase) in human neurons
Jorge Gomez
2018–2019 · award
New directions for early diagnosis of MND: a large-scale longitudinal analysis of multiple biomarkers to find diagnostic and prognostic "fingerprints"
Gilles Guillemin
2018–2021 · award
Expanded Population of Regulatory T-Cells (EPAR T-Cells) for People with Amyotrophic Lateral Sclerosis (PALS)
James Berry
2018–2022 · award
Identification, characterization and validation of modifiers of repeat RNA toxicity in C9orf72 amyotrophic lateral sclerosis (ALS)
Ludo Van Den Bosch
2018–2021 · award
Gene therapy strategy to strength neuromuscular junction in ALS
Danilo Medinas
2018 · award
A software platform for deploying patient-level predicitve models into ALS clinics
David Ennist
2018 · award
RAGE inhibition as a therapeutic approach in ALS models
Mariana Pehar
2018–2020 · award
Contributions of astrocyte function and dysfunction to ALS
Sara Ackerman
2018 · award
Neuromuscular sensing system usability testing for ALS patients
Salil Patel
2018–2020 · award
Programming human chaperone systems against neurodegenerative disease
Edward Barbieri
2018 · award
ALS treatments: targeted therapeutic gene delivery to motor neurons using novel non-viral nano-constructs called immunogenes
Roshan Vasani
2018–2021 · award
Identification of the molecular mechanisms of KIF5A mutations towards the development of ALS vs. HSP
John Landers
2018–2020 · award
Selective neuronal vulnerability and resistance to pTDP-43 pathology in the primary motor and visual cortices of ALS patients
Matthew Cykowski
2018–2020 · award
Trancriptome biomarker discovery in ALS
Mercedes Prudencio
2018–2022 · award
Early markers of disease in C9ORF72 ALS
Katharine Nicholson
2018–2021 · award
Pathological analysis of selective authophagy in sporadic and familial ALS
Timothy Miller
2018–2022 · award
Integrase inhibitors as a therapeutic modality for ALS
Renée Douville
2018–2020 · award
Investigating pridopidine, a Sigma-1 receptor activator, as a novel therapeutic treatment for ALS
John Landers
2018–2022 · award
Building an ALS disease model and user interface via GNS Healthcare REFS big data platform
Jeanne Latourelle
2018–2019 · award
Pathological analysis of selective authophagy in sporadic and familial ALS
John Ravits
2018–2019 · award
Identification of proteomic signatures in T cells in ALS
Oleg Butovsky
2018–2021 · award
A randomised controlled study of psychological intervention in ALS to address the significant and complex mental health issues facing caregivers
Orla Hardiman
2018–2019 · award
The actin cytoskeleton as a novel pathway in ALS pathogenesis
Eric Vitriol
2018–2021 · award
Presymptomatic biomarkers of C9-ALS/FTD
Laura Ranum
2018–2019 · award
Community-based genetic testing and tele-genetic counseling for patients with ALS
Jonathan Glass
2018–2020 · award
Pre-symptomatic neurofilament light chain as biomarker in amyotrophic lateral sclerosis
Kjetil Bjornevik
2018–2021 · award
Effect of Ataxin-2 intermediate length polyglutamine expansion on TDP-43 RNP granule dynamics
Pallavi Gopal
2018–2019 · award
Discovery of genetic disease modifiers accounting for substantial variability in survival after ALS onset
Marka Van Blitterswijk
2018–2021 · award
Utility of 3D printed masks for improving compliance and efficacy of non-invasive ventilation in subjects with amyotrophic lateral sclerosis: a pilot feasibility study
Stephen Goutman
2018–2021 · award
Investigating aerosolized cyanobacteria in Amyotrophic Lateral Sclerosis
Elijah Stommel
2018–2020 · award
Alleviation of pathological mechanisms of genetically defined ALS by small molecules targeting RNA G4C2 repeat expansions
Andrei Ursu
2018–2020 · award
Mechanisms underlying neuronal dysfunction and degeneration in ALS caused by mutation of PFN1
Anne C. Hart
2018–2019 · award
Maintain the SOD1 breeding colony in 2017
Taconic Biosciences
2018–2022 · award
Delivery of silencing RNAs targeting Ataxin-2 and C9ORF72 repeat intron for the treatment of ALS
Derrick Gibbings
2018–2020 · award
Clinical development of AT-1501, a humanized antibody targeting CD40LG, in ALS patients
Steven Perrin